Egrifta Interactions
There are 48 drugs known to interact with Egrifta (tesamorelin), along with 3 disease interactions. Of the total drug interactions, 48 are moderate.
- View all 48 medications that may interact with Egrifta
- View Egrifta disease interactions (3)
Most frequently checked interactions
View interaction reports for Egrifta (tesamorelin) and the medicines listed below.
- acyclovir
- Adderall (amphetamine / dextroamphetamine)
- amlodipine
- Aspirin Low Strength (aspirin)
- atorvastatin
- Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- Cialis (tadalafil)
- Descovy (emtricitabine / tenofovir alafenamide)
- doxycycline
- fenofibrate
- finasteride
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- ibuprofen
- Intelence (etravirine)
- Isentress (raltegravir)
- ketoconazole topical
- lisinopril
- Lyrica (pregabalin)
- metformin
- montelukast
- naproxen
- pantoprazole
- prednisone
- rosuvastatin
- tramadol
- trazodone
- Truvada (emtricitabine / tenofovir disoproxil)
- Vitamin D3 (cholecalciferol)
Egrifta disease interactions
There are 3 disease interactions with Egrifta (tesamorelin) which include:
More about Egrifta (tesamorelin)
- Egrifta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (18)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.